Hims & Hers Health, UnitedHealth Group, Eli Lilly and Company, Blueprint Medicines, Onsemi, Walmart, and Merck & Co., Inc. are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector, including pharmaceuticals, biotechnology, medical device manufacturers and healthcare service providers. By buying these stocks, investors gain exposure to potential growth driven by drug approvals, medical innovations and demographic trends. Their performance is often influenced by clinical trial results, regulatory decisions and changes in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Shares of Hims & Hers Health stock traded down $1.18 during midday trading on Wednesday, reaching $53.55. The company had a trading volume of 43,240,477 shares, compared to its average volume of 20,322,212. The company has a market capitalization of $11.99 billion, a price-to-earnings ratio of 121.71 and a beta of 1.84. Hims & Hers Health has a 1-year low of $13.47 and a 1-year high of $72.98. The stock has a fifty day simple moving average of $40.77 and a 200 day simple moving average of $36.56.
Read Our Latest Research Report on HIMS
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
NYSE:UNH remained flat at $301.22 during trading hours on Wednesday. 7,252,350 shares of the company's stock traded hands, compared to its average volume of 10,838,967. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $273.25 billion, a P/E ratio of 19.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm has a 50 day moving average price of $422.31 and a 200 day moving average price of $489.42.
Read Our Latest Research Report on UNH
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
NYSE LLY traded up $18.55 on Wednesday, reaching $769.33. The company had a trading volume of 1,359,709 shares, compared to its average volume of 3,630,103. The company's fifty day moving average is $773.82 and its 200-day moving average is $799.64. Eli Lilly and Company has a 1-year low of $677.09 and a 1-year high of $972.53. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15. The firm has a market capitalization of $729.12 billion, a price-to-earnings ratio of 65.70, a price-to-earnings-growth ratio of 1.40 and a beta of 0.48.
Read Our Latest Research Report on LLY
Blueprint Medicines (BPMC)
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.
Shares of NASDAQ:BPMC traded up $0.42 during midday trading on Wednesday, hitting $128.02. The stock had a trading volume of 7,465,810 shares, compared to its average volume of 1,075,751. The company has a market cap of $8.27 billion, a P/E ratio of -118.54 and a beta of 0.83. Blueprint Medicines has a 12 month low of $73.04 and a 12 month high of $128.15. The business's 50-day simple moving average is $93.17 and its 200-day simple moving average is $95.16. The company has a quick ratio of 2.80, a current ratio of 2.85 and a debt-to-equity ratio of 1.15.
Read Our Latest Research Report on BPMC
Onsemi (ON)
onsemi is engaged in disruptive innovations and also a supplier of power and analog semiconductors. The firm offers vehicle electrification and safety, sustainable energy grids, industrial automation, and 5G and cloud infrastructure, with a focus on automotive and industrial end-markets. It operates through the following segments: Power Solutions Group, Advanced Solutions Group, and Intelligent Sensing Group.
Shares of Onsemi stock traded up $2.99 during trading on Wednesday, hitting $50.36. 15,967,848 shares of the stock were exchanged, compared to its average volume of 7,952,639. The company has a fifty day moving average price of $39.59 and a 200-day moving average price of $50.75. The stock has a market capitalization of $21.04 billion, a price-to-earnings ratio of 13.87, a price-to-earnings-growth ratio of 16.74 and a beta of 1.39. The company has a current ratio of 5.06, a quick ratio of 3.38 and a debt-to-equity ratio of 0.38. Onsemi has a 1-year low of $31.04 and a 1-year high of $80.08.
Read Our Latest Research Report on ON
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
Shares of WMT traded down $0.07 during trading hours on Wednesday, hitting $99.91. The company had a trading volume of 4,768,134 shares, compared to its average volume of 17,850,777. The business has a fifty day moving average of $94.05 and a 200-day moving average of $93.63. The company has a quick ratio of 0.23, a current ratio of 0.82 and a debt-to-equity ratio of 0.40. The firm has a market cap of $799.37 billion, a price-to-earnings ratio of 41.46, a PEG ratio of 4.42 and a beta of 0.69. Walmart has a 12 month low of $65.64 and a 12 month high of $105.30.
Read Our Latest Research Report on WMT
Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
MRK traded up $1.89 on Wednesday, reaching $79.03. The company had a trading volume of 5,428,157 shares, compared to its average volume of 12,602,886. The company's fifty day moving average is $79.75 and its 200 day moving average is $90.29. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.15 and a current ratio of 1.36. The stock has a market cap of $198.45 billion, a P/E ratio of 11.74, a P/E/G ratio of 0.77 and a beta of 0.43. Merck & Co., Inc. has a fifty-two week low of $73.31 and a fifty-two week high of $134.63.
Read Our Latest Research Report on MRK
See Also
Before you consider Hims & Hers Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims & Hers Health wasn't on the list.
While Hims & Hers Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
